Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNMT | P11086 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.32 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6550988 | 1.00 | PNMT (0.34) | PNMTAKR1C3TAAR1CNR2LTB4R | |
| SCHEMBL7804623 | 0.83 | GABRA1 (0.38) | PNMTAKR1C3TAAR1CNR2LTB4R | |
| SCHEMBL12152309 | 0.83 | GABRA1 (0.38) | PNMTAKR1C3TAAR1CNR2LTB4R | |
| SCHEMBL3894782 | 0.82 | TP53 (0.43) | PNMTTAAR1SIGMAR1HTR2AHTR2C | |
| SCHEMBL29668408 | 0.80 | PNMT (0.44) | PNMTTAAR1SIGMAR1HTR2AHTR2C | |
| SCHEMBL13614407 | 0.73 | OPRM1 (0.40) | AKR1C3TAAR1CNR2LTB4RLTB4R2 | |
| SCHEMBL25383248 | 0.72 | MAOA (0.48) | LTB4RLTB4R2MAOACYP4F2CYP4A11 | |
| SCHEMBL610896 | 0.72 | CNR2 (0.38) | CNR2LTB4RLTB4R2MAOACYP4F2 | |
| SCHEMBL13859025 | 0.72 | TSHR (0.39) | CNR2LTB4RLTB4R2CYP4F2CYP4A11 | |
| SCHEMBL7489493 | 0.72 | ALDH1A1 (0.39) | CNR2LTB4RLTB4R2CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1034169-B1 | TRISARYL-1,3,5-TRIAZINE ULTRAVIOLET LIGHT ABSORBERS | CIBA SC HOLDING AG (CH) | 2004-02-11 | — | — | EP | disclosed |
| US-6365652-B2 | AMIDO OR CARBAMATE SUBSTITUTED TRISARYL-1,3,5-TRIAZINES USED AS ACTINIC RADIATION STABILIZER BY INCORPORATING THE ABOVE COMPOUND INTO THE ORGANIC POLYMER BY CHEMICAL BONDING | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-04-02 | — | — | US | disclosed |
| US-20010037022-A1 | Trisaryl-1,3,5-triazine ultraviolet light absorbers | GUPTA RAM BABOO (US) | 2001-11-01 | — | — | US | disclosed |
| US-6265576-B1 | STABILIZERS | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-07-24 | — | — | US | disclosed |
| EP-1034169-A1 | TRISARYL-1,3,5-TRIAZINE ULTRAVIOLET LIGHT ABSORBERS | Ciba SC Holding AG (CH) | 2000-09-13 | — | — | EP | disclosed |
| WO-1999026935-A1 | TRISARYL-1,3,5-TRIAZINE ULTRAVIOLET LIGHT ABSORBERS | CYTEC TECHNOLOGY CORP. (US) | 1999-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010037022-A1 | Trisaryl-1,3,5-triazine ultraviolet light absorbers | CRYZ, ERCC5, TELO2 | PNMT 2691/4885AKR1C3 1263/4885TAAR1 1139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.